Literature DB >> 18509852

Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia.

Rosalinda C Roberts1, Joy K Roche, Robert R Conley.   

Abstract

Subjects with schizophrenia (SZ) have an increased density of synapses characteristic of corticostriatal or thalamostriatal glutamatergic inputs in the caudate matrix and putamen patches. SZ is a heterogeneous disease in many aspects including symptoms. The purpose of the present study was to determine if the synaptic organization in two different DSM-i.v. subgroups of SZ was differentially affected. Postmortem striatal tissue was obtained from the Maryland Brain Collection from normal controls (NC), chronic paranoid SZs (SZP), and chronic undifferentiated SZs (SZU). Tissue was prepared for calbindin immunocytochemistry to identify patch matrix compartments, prepared for electron microscopy and analyzed using stereological methods. The synaptic density of asymmetric synapses, characteristic of glutamatergic inputs, was elevated equivalently in striatal patches in the SZP and SZU versus NC. The SZU also had an increased density of asymmetric synapses in the striatal matrix compared to NC. Moreover, symmetric axospinous synapses, characteristic of intrinsic inhibitory inputs and dopaminergic afferents, showed a dichotomy in synaptic density between the SZU and SZP in the striatal and caudate matrix. These data show discreet differences in synaptic organization between SZU and SZP and/or NCs. The results suggest that abnormal corticostriatal and/or corticothalamic inputs to striatal patches may be related to limbic dysfunction, which is perturbed in both subtypes of SZ. The selective increase in axospinous synapses in the matrix of the SZU subgroup compared to the SZP may be related to more severe cognitive problems in that subset of SZ compared to SZP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509852     DOI: 10.1002/syn.20534

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  18 in total

1.  Elevated Excitatory Input to the Nucleus Accumbens in Schizophrenia: A Postmortem Ultrastructural Study.

Authors:  Lesley A McCollum; Courtney K Walker; Joy K Roche; Rosalinda C Roberts
Journal:  Schizophr Bull       Date:  2015-03-27       Impact factor: 9.306

Review 2.  Postmortem studies on mitochondria in schizophrenia.

Authors:  Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2017-02-09       Impact factor: 4.939

3.  RIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophrenia.

Authors:  Jacqueline Blundell; Pascal S Kaeser; Thomas C Südhof; Craig M Powell
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

4.  The SNAP25 Interactome in Ventromedial Caudate in Schizophrenia Includes the Mitochondrial Protein ARF1.

Authors:  Alfredo Ramos-Miguel; Vilte Barakauskas; Jehan Alamri; Masatoshi Miyauchi; Alasdair M Barr; Clare L Beasley; Gorazd Rosoklija; J John Mann; Andrew J Dwork; Annie Moradian; Gregg B Morin; William G Honer
Journal:  Neuroscience       Date:  2019-01-02       Impact factor: 3.590

5.  Association of the Met-196-Arg variation of human tumor necrosis factor receptor 2 (TNFR2) with paranoid schizophrenia.

Authors:  Sihem Thabet; Mouna Ben Nejma; Ferid Zaafrane; Lotfi Gaha; Kamel Ben Salem; Abdelaziz Romdhane; Mohamed Nour; Besma Bel Hadj Jrad
Journal:  J Mol Neurosci       Date:  2010-09-15       Impact factor: 3.444

Review 6.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

Review 7.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

8.  Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.

Authors:  R C Roberts; K A Barksdale; J K Roche; A C Lahti
Journal:  Schizophr Res       Date:  2015-07-22       Impact factor: 4.939

9.  Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response.

Authors:  Rosalinda C Roberts; Joy K Roche; Robert R Conley; Adrienne C Lahti
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

10.  A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia.

Authors:  Vilte E Barakauskas; Clare L Beasley; Alasdair M Barr; Athena R Ypsilanti; Hong-Ying Li; Allen E Thornton; Hubert Wong; Gorazd Rosokilja; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasha Davceva; Boro Ilievski; Andrew J Dwork; Peter Falkai; William G Honer
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.